Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis.
about
Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report.Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.
P2860
Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis.
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Factor V Leiden mutation inves ...... s with and without thrombosis.
@ast
Factor V Leiden mutation inves ...... s with and without thrombosis.
@en
type
label
Factor V Leiden mutation inves ...... s with and without thrombosis.
@ast
Factor V Leiden mutation inves ...... s with and without thrombosis.
@en
prefLabel
Factor V Leiden mutation inves ...... s with and without thrombosis.
@ast
Factor V Leiden mutation inves ...... s with and without thrombosis.
@en
P2093
P1433
P1476
Factor V Leiden mutation inves ...... s with and without thrombosis.
@en
P2093
Castro-Malaspina H
Luzzatto L
Vulliamy T
P304
P577
1996-11-01T00:00:00Z